Natalie Kofler is a trained molecular biologist and the founding director of Editing Nature - a global initiative to steer responsible development and deployment of environmental genetic technologies. She builds deliberative platforms that engage diverse expertise, worldviews, and lived experiences to foster effective public engagement, promote wise innovation, and inform sensible policy.
She is a leading voice in CRISPR and synthetic biology ethics and governance, authoring numerous publications on the topic, serving on expert panels, and contributing to UN mandated documents. Her work has been highlighted by The New York Times, Science, Nature, NPR, CBC radio, Pacific Standard Magazine, and National Geographic. She lectures on environmental ethics at the Center for Biomedical Ethics at Harvard Medical School. She served as the resident scholar in sustainability a the University of Illinois, a visiting scholar at the Hastings Center for Bioethics, and is an affiliate scholar at the Yale Program in Biomedical Ethics. She received her PhD in cellular, molecular, and medical biosciences and MS in human nutrition and metabolic studies from Columbia University and her BS in human anatomy and cell biology from McGill University. She is an advisor for the Scientific Citizenship Initiative at Harvard Medical School.
Experience
-
2020–presentAdvisor, Scientific Citizenship Initiative, Harvard Medical School
-
2019–presentAffiliated Scholar, Yale Interdisciplinary Center for Bioethics
-
2019–presentAssociate Scholar, Solomon Center for Health Law and Policy at Yale Law School
-
–presentFounder of Editing Nature, Yale University
-
2018–presentLecturer, Harvard Medical School Center for Bioethics
-
2019–2020Resident Scholar, University of Illinois Institute for Sustainability, Energy and Environment
-
2014–2017Postdoctoral research fellow, Yale University
Education
-
2013Columbia University, PhD
-
2007Columbia University, MS
-
2006McGill University, BS
Publications
-
2020Ten reasons why immunity passports are a bad idea, Nature
-
2019Why were scientists silent over gene-edited babies?, Nature
-
2019Dished brains and designed babies, Nature
-
2019Gene drives: yelling match drowns out marginalized voices, Nature
-
2019Tempering tech with wisdom, Earth Island Journal
-
2018The Rab-effector protein RABEP2 regulates endosomal trafficking to mediate vascular growth factor-2, Journal of Biological Chemistry
-
2018Treatment of heritable disease using CRISPR: hopes, fears, and reality, Seminars in Perinatology
-
2018Editing nature: Local roots of global governance, Science
-
2016The expanding role of neuropilin: regulation of transforming growth factor-beta and platelet-derived growth factor signaling in the vasculature, Current Opinion in Hematology
-
2015Combined deficiency of Notch1 and Notch3 causes pericyte dysfunction, models CADASIL, and results in arteriovenous malformations, Scientific Reports
-
2015Angiogenesis versus arteriogenesis: neuropilin-1 modulation of VEGF signaling, F1000
-
2011Notch signaling in developmental and tumor angiogenesis, Genes and Cancer
- Currently in Parry Sound, ON, Canada
- Website
- @nataliekofler
- Article Feed
- Joined
